Safety Study of Replication-competent Adenovirus (Delta-24-rgd) in Patients With Recurrent Glioblastoma

NCT01582516 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Brain Tumor
Recurring Glioblastoma

Interventions

BIOLOGICAL: delta-24-RGD adenovirus

Sponsor

Erasmus Medical Center

Collaborators

[object Object]